TerminatedNot Applicable

FSHD Molecular Characterization

Stopped: This study was closed due to inability to to recruit.

United States1 participantsStarted 2021-03-05

Plain-language summary

To characterize the clinical and molecular phenotype of FSHD.

Who can participate

Age range13 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 13 years or older * Genetically proven FSHD1 or FSHD2 as determined by the investigators Exclusion Criteria: * Inability to complete an MRI scan (Adults only). * Other medical or cognitive issues that, in the opinion of the examiner, preclude accurate functional assessment.

What they're measuring

Validation of Biomarkers

Timeframe: Through study completed, anticipated to be 4 years.

Trial details

NCT IDNCT06096441

SponsorNationwide Children's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-09

View on ClinicalTrials.gov More Facio-Scapulo-Humeral Dystrophy trials